Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification

Myelodysplastic syndromes (MDS) have varied prognoses and require a risk-adapted treatment strategy for treatment optimization. Recently, a molecular prognostic model (Molecular International Prognostic Scoring System [IPSS-M]) that combines clinical parameters, cytogenetic abnormalities, and mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wan-Hsuan, Tsai, Ming-Tao, Tsai, Cheng-Hong, Tien, Feng-Ming, Lo, Min-Yen, Tseng, Mei-Hsuan, Kuo, Yuan-Yeh, Liu, Ming-Chih, Yang, Yi-Tsung, Chen, Jui-Che, Tang, Jih-Luh, Sun, Hsun-I, Chuang, Yi-Kuang, Lin, Liang-In, Chou, Wen-Chien, Lin, Chien-Chin, Hou, Hsin-An, Tien, Hwei-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412560/
https://www.ncbi.nlm.nih.gov/pubmed/37558665
http://dx.doi.org/10.1038/s41408-023-00894-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412560/
https://www.ncbi.nlm.nih.gov/pubmed/37558665
http://dx.doi.org/10.1038/s41408-023-00894-8

Ejemplares similares